Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q3 2025 Earnings

12AugConfirmed

Q3 2024

Q4 2024

Q2 2025

Q3 2025

-1

-0.78

-0.57

-0.35

Details

Expected EPS

-0.458333

Actual EPS

-0.35

Surprise EPS

0.11

Surprise Percent

+23.64%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.35 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.